eMedicine Specialties > Neurosurgery > Neoplasm

Intramedullary Spinal Cord Tumors: Workup

Author: Alfred T Ogden, MD, Assistant Professor, Department of Neurological Surgery, Columbia University Medical Center
Coauthor(s): Nicholas Wetjen, MD, Pediatric Neurosurgery Fellow, University of Utah, Primary Children's Hospital; Thomas L Francavilla, MD, Chief of Neurosurgery Section, Department of Surgery, Brookwood Medical Center
Contributor Information and Disclosures

Updated: Apr 9, 2009

Workup

Laboratory Studies

No laboratory tests are specific or sensitive for tumors arising from the spinal cord.

Imaging Studies

  • Plain radiographs of the spine cannot diagnose an intramedullary tumor but may be useful for surgical planning if the tumor is associated with a deformity.
  • Myelography has now been surpassed by MRI and is used mainly when MRI is not available.
  • Spinal angiography and embolization can be useful in cases of hemangioblastoma.
  • MRI produces exquisite detail of the spinal cord.
    • Most tumors are isointense or slightly hypointense compared with the normal cord signal.
    • Tumors generally exhibit some enhancement with gadolinium, and this enhancement may be homogenous or irregular (Images 1, 2, 3).
    • Contrast-enhanced MRI is very sensitive for tumors and may disclose minute lesions.
  • Determining whether an abnormal MRI definitively indicates the presence of a tumor can be problematic. MRI alone does not guarantee an accurate diagnosis in every case and the clinical history and neurologic examination help to avoid unnecessary surgery on multiple sclerosis plaques or vascular or inflammatory myelitis.
    • The spinal cord appears enlarged when a tumor is present, while inflammatory lesions result in a normal or minimal increase in cord size appearance.
    • In cases where a syrinx is noted (see Image 1), one must distinguish a primary syrinx from a tumor-associated syrinx. Therefore, a search for a Chiari malformation or abnormal contrast enhancement must be undertaken.
  • Some tumors have a tendency to occur in multiple areas, and imaging the entire neuroaxis may be indicated (eg, hemangioblastoma).
  • The differential diagnosis of a patient presenting only with back pain is legion and most commonly is the result of degenerative spine disease. The contrast-enhanced MRI characteristics of the spinal cord have greatly simplified the diagnosis of intrinsic spinal cord tumors. However, diagnosis still can be problematic, as follows:
    • Syrinx (see Image 1) - Multiple causes, including tumor
    • Multiple sclerosis - May show multiple lesions of neuraxis
    • Transverse myelitis
    • Cord infarction
    • Abscess
    • Tuberculosis
    • Hematoma
    • Herniated disk
    • Spondylosis
    • Cord contusion
    • Extradural neoplasm
    • Intradural extramedullary neoplasm
    • Arteriovenous malformation and fistulae
    • Arachnoid cyst
    • Sarcoidosis (see Image 3 and Image 4) and other granulomatous diseases
    • Amyloid angiopathy

Other Tests

Electrophysiologic testing is generally not useful in the diagnosis and preoperative management of these tumors. These modalities may be of more value in monitoring cord function during tumor resection.

Diagnostic Procedures

  • Lumbar puncture
    • In the case of a complete spinal block by the tumor, this procedure may precipitate a disastrous shift in the intrathecal contents.
    • This should not be the first test performed when a spinal cord tumor is suspected.
    • Cerebrospinal fluid (CSF) may show extremely elevated protein levels, and xanthochromia may be present.

Histologic Findings

Ependymoma (40-60% in adults, 30% in children)

The most common intrinsic spinal cord tumor has a male predilection and a mean age of presentation of 35-40 years. They occur anywhere in the cord and are commonly in the conus medullaris, where an exophytic component may be present. They rarely change growth characteristics and metastasize.

Lesions are characteristically hypovascular, well circumscribed, and noninfiltrative of the surrounding cord.  Sometimes they are associated with a cystic "capping” of the tumor poles (see Image 1). Symptoms are due a chronic dilation of neural tissue rather than infiltration. Complete resection often results in a cure.

The first panel shows a cervical syrinx. The diff...

The first panel shows a cervical syrinx. The differential diagnosis for syrinx includes trauma, Chiari malformation, and dysmerogenesis. A syrinx can also be the by product of a tumor, which may be distant anatomically from the associated syrinx. The second panel shows a small enhancing ependymoma of the thoracic spine that was found during the workup for the cervical syrinx.

The first panel shows a cervical syrinx. The diff...

The first panel shows a cervical syrinx. The differential diagnosis for syrinx includes trauma, Chiari malformation, and dysmerogenesis. A syrinx can also be the by product of a tumor, which may be distant anatomically from the associated syrinx. The second panel shows a small enhancing ependymoma of the thoracic spine that was found during the workup for the cervical syrinx.


Various histological subtypes exist; however, the only salient feature that influences prognosis is anaplasia.

Astrocytoma (35-45% in adults, 60% in children)

These lesions are more common in children than in adults. Sometimes they are associated with microcysts or syringes. The pilocytic varieties are well differentiated and tend to be indolent, with a definable surgical plane.

The remainder of low-grade astrocytomas are infiltrative and impossible to resect completely. Residual tumor often has an indolent course, and controversy exists in the management of such tumors.

Fortunately, anaplastic astrocytoma or glioblastoma are rare. These malignant tumors exhibit rapid growth, are locally invasive, and may seed the CSF. Distinguishing between tumor and normal cord is difficult. Aggressive surgical resection has a controversial role with such tumors.

Hemangioblastoma (3-6%)

This is a vascular tumor that is associated with von Hippel-Lindau disease in 30% of cases. They often have an associated syrinx and occur in multiple locations. These should not be removed in a piecemeal fashion because significant bleeding may ensue, increasing the risk of the procedure. Removal of the lesion is considered curative.

Developmental tumors (2%)

Dermoid, epidermoid, and teratoma are slow-growing neoplasms with a thoracolumbar predominance. Some dermoids of the conus medullaris have been attributed to lumbar punctures that carry in cutaneous tissue.

These may have a dense capsule, precluding complete removal; although, this may be compatible with prolonged symptom-free survival. When complete removal is unobtainable, debris produced by the tumor may cause an early recurrence of symptoms.

Lipoma (2%)

Not true neoplasms, Lipomas present in the first 3 decades of life when fat is being deposited. They may be associated with cutaneous abnormalities. Loss of total body fat may be necessary to reduce the mass of the tumor.

Fibrous adhesions to the cord make total removal difficult. Removal is not the goal of surgery. The carbon dioxide laser is particularly useful during surgery for this lesion.1

Others (4%)

Unusual lesions include subependymoma, ganglioglioma and intramedullary schwannoma, and neurofibroma. Management of low-grade lesions parallels other indolent lesions. Metastatic lesions to the spinal cord are unusual. Large series defining the management of these tumors are not available.

More on Intramedullary Spinal Cord Tumors

Overview: Intramedullary Spinal Cord Tumors
Workup: Intramedullary Spinal Cord Tumors
Treatment: Intramedullary Spinal Cord Tumors
Follow-up: Intramedullary Spinal Cord Tumors
Multimedia: Intramedullary Spinal Cord Tumors
References

References

  1. Lee M, Rezai AR, Abbott R, et al. Intramedullary spinal cord lipomas. J Neurosurg. Mar 1995;82(3):394-400. [Medline].

  2. Kothbauer K, Deletis V, Epstein FJ. Intraoperative spinal cord monitoring for intramedullary surgery: an essential adjunct. Pediatr Neurosurg. May 1997;26(5):247-54. [Medline].

  3. Cristante L, Herrmann HD. Surgical management of intramedullary spinal cord tumors: functional outcome and sources of morbidity. Neurosurgery. Jul 1994;35(1):69-74; discussion 74-6. [Medline].

  4. Sgouros S, Malluci CL, Jackowski A. Spinal ependymomas--the value of postoperative radiotherapy for residual disease control. Br J Neurosurg. Dec 1996;10(6):559-66. [Medline].

  5. Jyothirmayi R, Madhavan J, Nair MK, et al. Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma. J Neurooncol. Jul 1997;33(3):205-11. [Medline].

  6. Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. Sep 1992;77(3):355-9. [Medline].

  7. Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg. Aug 1993;79(2):204-9. [Medline].

  8. Greenwood J Jr. Surgical removal of intramedullary tumors. J Neurosurg. Feb 1967;26(2):276-82. [Medline].

  9. Hoshimaru M, Koyama T, Hashimoto N, et al. Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases. Neurosurgery. Feb 1999;44(2):264-9. [Medline].

  10. Lee M, Epstein FJ, Rezai AR, et al. Nonneoplastic intramedullary spinal cord lesions mimicking tumors. Neurosurgery. Oct 1998;43(4):788-94; discussion 794-5. [Medline].

  11. Malis LI. Intramedullary spinal cord tumors. Clin Neurosurg. 1978;25:512-39. [Medline].

  12. McCormick PC, Torres R, Post KD, et al. Intramedullary ependymoma of the spinal cord. J Neurosurg. Apr 1990;72(4):523-32. [Medline].

  13. Ogden, AT and McCormick, PC. Intradural Spinal Tumors. In: Bernstein, M and Berger, MS. Neuro-oncology: The Essentials. 2. New York: Thieme; 2008:36: 379-390.

  14. Sandler HM, Papadopoulos SM, Thornton AF Jr, et al. Spinal cord astrocytomas: results of therapy. Neurosurgery. Apr 1992;30(4):490-3. [Medline].

  15. Stein BM, McCormick PC. Intramedullary neoplasms and vascular malformations. Clin Neurosurg. 1992;39:361-87. [Medline].

  16. Stein BM, McCormick PC. Spinal intradural tumors. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York, NY: McGraw-Hill; 1996:1769-89.

Further Reading

Keywords

spinal cord, intramedullary spinal tumors, intramedullary spinal cord tumor, intrinsic spinal tumors, intrinsic spinal tumor, spinal cord tumors, spinal cord tumor, intramedullary tumors, intramedullary tumor, intradural spinal tumors, intradural spinal tumor, intramedullary, spinal cord, tumors, tumor, spine tumors, spine tumor, spinal tumors, spinal tumor, spinal 

Contributor Information and Disclosures

Author

Alfred T Ogden, MD, Assistant Professor, Department of Neurological Surgery, Columbia University Medical Center
Alfred T Ogden, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, and Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Coauthor(s)

Nicholas Wetjen, MD, Pediatric Neurosurgery Fellow, University of Utah, Primary Children's Hospital
Nicholas Wetjen, MD is a member of the following medical societies: American Association of Neurological Surgeons and Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Thomas L Francavilla, MD, Chief of Neurosurgery Section, Department of Surgery, Brookwood Medical Center
Thomas L Francavilla, MD is a member of the following medical societies: American Association of Neurological Surgeons and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Duc Hoang Duong, MD, Professor, Chief Physician, Departments of Neurological Surgery and Neuroscience, Epilepsy Center, Charles R Drew University
Duc Hoang Duong, MD is a member of the following medical societies: American Neurological Association, Congress of Neurological Surgeons, and North American Skull Base Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ryszard M Pluta, MD, PhD, Associate Professor, Neurosurgical Department Medical Research Center, Polish Academy of Sciences at Warsaw, Poland; Senior Researcher, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH
Ryszard M Pluta, MD, PhD is a member of the following medical societies: Congress of Neurological Surgeons and Polish Society of Neurosurgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.